Infants who were exposed in utero to Zika virus (ZIKV) during the epidemic of 2015 to 2016 in Central and South America have aged into early childhood. Currently, there is a need to understand the spectrum of neurodevelopmental outcomes in children with congenital ZIKV exposure and to provide appropriate follow-up and neurodevelopmental interventions to at-risk children. Quiz Ref ID Outcomes are poor in infants with severe neurologic abnormalities associated with congenital Zika syndrome (CZS), which includes microcephaly, global neurodevelopmental delay, epilepsy, visual impairment, and deafness.
1,2 However, most newborns with prenatal ZIKV exposure do not have clinical manifestations of CZS.
3 The risk and spectrum of neurodevelopmental impairment in infants without CZS after exposure to prenatal ZIKV are not yet known but are of major importance given the large number of children exposed to ZIKV without apparent neurologic abnormalities at birth.